title: Adherence and adequacy of therapy for esophageal varices prophylaxis.
abstract: OBJECTIVE
  Esophageal varices (EVs) are prevalent among cirrhotics and their bleeding leads to substantial morbidity and mortality. Management guidelines available during this study recommended beta-blocker therapy for primary prophylaxis and beta-blocker or band ligation (EVL) for secondary prophylaxis. We evaluated prophylaxis practice patterns.
  
  
  METHODS
  We performed a retrospective cohort study of in and outpatient cirrhotics with known EVs at two University of Texas Southwestern teaching institutions. Use of prophylactic therapy and its adequacy (defined using published guidelines) was measured.
  
  
  RESULTS
  A total of 419 patients with cirrhosis and EVs warranting prophylaxis were identified, including 276 inpatients and 143 outpatients. Of those admitted with a first bleed (i.e. eligible for primary prophylactic therapy), 30/104 (29%) were on beta blocker. In this group, only 3/104 (3%) received optimal therapy (heart rate <55). Among inpatients with a previous EV bleed, 120/172 (70%) were on a beta blocker or had undergone EVL, although only 66/172 (38%) received optimal therapy. In the inpatient cohort, ten patients died of gastrointestinal hemorrhage, three of whom were receiving optimal therapy. Among outpatients, 94/121 (78%) without previous bleeding received primary prophylaxis and 20/22 (91%) of those with previous bleeding received some form of secondary prophylaxis. However, only 11 (9%) received adequate primary prophylaxis therapy, while 9 (41%) received appropriate secondary prophylaxis.
  
  
  CONCLUSIONS
  Prophylaxis intent appears to be greatly improved compared to previous reports. However, implementation of optimal therapy appeared to be suboptimal. We conclude that efforts need to be made to ensure optimal treatment.
authors: Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-8887, USA.
authors: Haripriya
authors: H
authors: Maddur
authors: Suraj
authors: S
authors: Naik
authors: Ali A
authors: AA
authors: Siddiqui
authors: Don C
authors: DC
authors: Rockey
references: Hepatology. 2000 Nov;32(5):930-4
references: 11050041
references: Am J Gastroenterol. 2003 Mar;98(3):653-9
references: 12650802
references: Hepatology. 2004 Sep;40(3):652-9
references: 15349904
references: Nat Clin Pract Gastroenterol Hepatol. 2005 Nov;2(11):526-35
references: 16355158
references: Clin Gastroenterol Hepatol. 2010 Aug;8(8):703-8
references: 20226879
references: Gastroenterology. 2004 Aug;127(2):476-84
references: 15300580
references: J Clin Gastroenterol. 2005 May-Jun;39(5):435-40
references: 15815213
references: Br J Surg. 1973 Aug;60(8):646-9
references: 4541913
references: J Lab Clin Med. 1967 Sep;70(3):442-51
references: 6066657
references: Gastroenterology. 1981 Apr;80(4):800-9
references: 6970703
references: Hepatology. 1995 Jul;22(1):332-54
references: 7601427
references: Am J Gastroenterol. 1997 Jul;92(7):1081-91
references: 9219775
references: J Hepatol. 2000 Nov;33(5):846-52
references: 11097497
references: Hepatology. 2003 Sep;38(3):599-612
references: 12939586
references: Hepatology. 2007 Sep;46(3):922-38
references: 17879356